Imunon (IMNN) Set to Announce Quarterly Earnings on Thursday

Imunon (NASDAQ:IMNN) is scheduled to post its quarterly earnings results before the market opens on Thursday, November 7th. Analysts expect Imunon to post earnings of ($0.37) per share for the quarter.

Imunon (NASDAQ:IMNN) last posted its earnings results on Wednesday, August 14th. The company reported ($0.51) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.04. On average, analysts expect Imunon to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Imunon Stock Performance

Imunon stock opened at $0.98 on Wednesday. The firm has a market capitalization of $58.87 million, a price-to-earnings ratio of -0.51 and a beta of 2.14. Imunon has a fifty-two week low of $0.48 and a fifty-two week high of $3.65. The stock’s fifty day moving average is $1.03 and its two-hundred day moving average is $1.21.

Analysts Set New Price Targets

Several analysts have weighed in on the company. HC Wainwright reissued a “buy” rating and issued a $14.00 target price on shares of Imunon in a report on Thursday, August 15th. EF Hutton Acquisition Co. I raised Imunon to a “strong-buy” rating in a research note on Monday, September 23rd.

About Imunon

Imunon, Inc, a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company’s lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development.